Deal
ABBOTT LABORATORIES acquires Cardiovascular Systems, Inc. (CSI)
April 2023
Full acquisition
Ready
01 Scorecard
The deal at a glance
Private-market deal
ABBOTT LABORATORIES acquires Cardiovascular Systems, Inc. (CSI)
Deal value
(not disclosed)
Sector
Medical devices — vascular
Date
April 2023
VectorShift
Made on VectorShift
ABBOTT LABORATORIES acquired Cardiovascular Systems, Inc. (CSI), a transaction completed in April 2023.
Cardiovascular Systems, Inc. (CSI) operates in Medical devices — vascular, is based in St. Paul, Minnesota, USA. Cardiovascular Systems, Inc. (CSI) makes an atherectomy system used in treating peripheral and coronary artery disease, adding complementary technologies to Abbott's portfolio of vascular device offerings.
CSI's atherectomy system adds complementary technologies to Abbott's portfolio of vascular device offerings.
Complementary atherectomy technology for Abbott Vascular. Integrated into Abbott's Medical Devices (Vascular) business
On April 27, 2023, Abbott completed the acquisition of Cardiovascular Systems, Inc. (CSI). CSI's atherectomy system, which is used in treating peripheral and coronary artery disease, adds complementary technologies to Abbott's portfolio of vascular device offerings.
Abbott FY2023 10-K, Item 1 Business
Advisors not disclosed
No advisory firms have been disclosed for this transaction.